Lista de obras - Libero Santarpia - Dominio Público Uruguay

A miRNA signature associated with human metastatic medullary thyroid carcinoma.

artículo científico

A novel von Hippel-Lindau point mutation presents as apparently sporadic pheochromocytoma.

artículo científico publicado en 2008

A serum microRNA signature predicts tumor relapse and survival in triple-negative breast cancer patients.

artículo científico publicado en 2014

Beyond RET: potential therapeutic approaches for advanced and metastatic medullary thyroid carcinoma.

scientific article published on July 2009

Breast cancer assessment tools and optimizing adjuvant therapy.

scientific article published on 26 October 2010

Cellular signaling pathway alterations and potential targeted therapies for medullary thyroid carcinoma

artículo científico publicado en 2013

DNA repair gene patterns as prognostic and predictive factors in molecular breast cancer subtypes.

artículo científico publicado en 2013

Detection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma

artículo científico publicado en 2009

Diabetes insipidus and panhypopituitarism due to intrasellar metastasis from medullary thyroid cancer

artículo científico publicado en 2009

Four patients with cutaneous metastases from medullary thyroid cancer

artículo científico publicado en 2008

Fulvestrant in the management of postmenopausal women with advanced, endocrine-responsive breast cancer.

artículo científico publicado en 2011

Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer.

artículo científico

Genetic alterations in the RAS/RAF/mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma

artículo científico publicado en 2010

Germline mutation of von Hippel-Lindau (VHL) gene 695 G>A (R161Q) in a patient with a peculiar phenotype with type 2C VHL syndrome

artículo científico publicado en 2006

Growth factor receptors expression in anaplastic thyroid carcinoma: potential markers for therapeutic stratification

artículo científico publicado en 2007

High resolution array-comparative genomic hybridization profiling reveals deoxyribonucleic acid copy number alterations associated with medullary thyroid carcinoma.

scientific article published on 02 September 2008

Human thyroid autoantigens and proteins of Yersinia and Borrelia share amino acid sequence homology that includes binding motifs to HLA-DR molecules and T-cell receptor.

artículo científico publicado en 2006

Hypercalcemia in cancer patients: pathobiology and management.

scientific article published on 03 December 2009

Inhibition of pituitary tumor‐transforming gene‐1 in thyroid cancer cells by drugs that decrease specificity proteins ⬇️

artículo científico publicado el 25 de enero de 2011

Inter- and intra-tumoral heterogeneity in DNA damage evaluated by comet assay in early breast cancer patients

artículo científico publicado en 2012

Lymphocytic hypophysitis: differential diagnosis and effects of high-dose pulse steroids, followed by azathioprine, on the pituitary mass and endocrine abnormalities--report of a case and literature review.

artículo científico publicado en 2010

Missense mutation in the transcription factor NKX2-5: a novel molecular event in the pathogenesis of thyroid dysgenesis

artículo científico publicado en 2006

Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers.

artículo científico publicado en 2012

Notch is a direct negative regulator of the DNA-damage response

artículo científico publicado en 2015

Phosphatidylinositol 3-kinase/akt and ras/raf-mitogen-activated protein kinase pathway mutations in anaplastic thyroid cancer

scientific article published on 07 November 2007

Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients

artículo científico publicado en 2011

Primary growth hormone insensitivity (Laron syndrome) and acquired hypothyroidism: a case report

artículo científico publicado en 2011

Prognostic and therapeutic implications of distinct kinase expression patterns in different subtypes of breast cancer

artículo científico publicado en 2010

Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers

artículo científico publicado en 2013

Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast.

artículo científico publicado en 2013

RET TKI: potential role in thyroid cancers.

artículo científico publicado en 2012

TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancers.

artículo científico publicado en 2014

Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy

artículo científico publicado en 2012

Targeting the microRNA-regulating DNA damage/repair pathways in cancer.

artículo científico publicado en 2014

Targeting triple negative breast cancer: is p53 the answer?

artículo científico

The evolving field of tyrosine kinase inhibitors in the treatment of endocrine tumors.

artículo científico publicado en 2010

The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms

artículo científico publicado en 2012

The role of topoisomerase IIalpha and HER-2 in predicting sensitivity to anthracyclines in breast cancer patients.

scientific article published on 15 September 2009

Triple negative breast cancer: a heterogeneous subgroup defined by what it is not.

artículo científico

Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors

artículo científico publicado en 2008

Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer

artículo científico publicado en 2012

Lista de obras de Libero Santarpia

A miRNA signature associated with human metastatic medullary thyroid carcinoma.

A novel von Hippel-Lindau point mutation presents as apparently sporadic pheochromocytoma.

A serum microRNA signature predicts tumor relapse and survival in triple-negative breast cancer patients.

Beyond RET: potential therapeutic approaches for advanced and metastatic medullary thyroid carcinoma.

Breast cancer assessment tools and optimizing adjuvant therapy.

Cellular signaling pathway alterations and potential targeted therapies for medullary thyroid carcinoma

DNA repair gene patterns as prognostic and predictive factors in molecular breast cancer subtypes.

Detection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma

Diabetes insipidus and panhypopituitarism due to intrasellar metastasis from medullary thyroid cancer

Four patients with cutaneous metastases from medullary thyroid cancer

Fulvestrant in the management of postmenopausal women with advanced, endocrine-responsive breast cancer.

Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer.

Genetic alterations in the RAS/RAF/mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma

Germline mutation of von Hippel-Lindau (VHL) gene 695 G>A (R161Q) in a patient with a peculiar phenotype with type 2C VHL syndrome

Growth factor receptors expression in anaplastic thyroid carcinoma: potential markers for therapeutic stratification

High resolution array-comparative genomic hybridization profiling reveals deoxyribonucleic acid copy number alterations associated with medullary thyroid carcinoma.

Human thyroid autoantigens and proteins of Yersinia and Borrelia share amino acid sequence homology that includes binding motifs to HLA-DR molecules and T-cell receptor.

Hypercalcemia in cancer patients: pathobiology and management.

Inhibition of pituitary tumor‐transforming gene‐1 in thyroid cancer cells by drugs that decrease specificity proteins ⬇️

Inter- and intra-tumoral heterogeneity in DNA damage evaluated by comet assay in early breast cancer patients

Lymphocytic hypophysitis: differential diagnosis and effects of high-dose pulse steroids, followed by azathioprine, on the pituitary mass and endocrine abnormalities--report of a case and literature review.

Missense mutation in the transcription factor NKX2-5: a novel molecular event in the pathogenesis of thyroid dysgenesis

Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers.

Notch is a direct negative regulator of the DNA-damage response

Phosphatidylinositol 3-kinase/akt and ras/raf-mitogen-activated protein kinase pathway mutations in anaplastic thyroid cancer

Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients

Primary growth hormone insensitivity (Laron syndrome) and acquired hypothyroidism: a case report

Prognostic and therapeutic implications of distinct kinase expression patterns in different subtypes of breast cancer

Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers

Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast.

RET TKI: potential role in thyroid cancers.

TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancers.

Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy

Targeting the microRNA-regulating DNA damage/repair pathways in cancer.

Targeting triple negative breast cancer: is p53 the answer?

The evolving field of tyrosine kinase inhibitors in the treatment of endocrine tumors.

The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms

The role of topoisomerase IIalpha and HER-2 in predicting sensitivity to anthracyclines in breast cancer patients.

Triple negative breast cancer: a heterogeneous subgroup defined by what it is not.

Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors

Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer